Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
RIGL
#2829
Rigel Pharmaceuticals Inc. (New)
31.390
0
USD
+4.74%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+4.74%
Changement Mensuel
+18.36%
Evolution sur 6 mois
+4.18%
Changement Annuel
+4.18%
Clôture Précédente
29.970
0
Open
31.390
0
Bid
Ask
Low
31.390
0
High
31.390
0
Volume
53
Marchés
Actions des Marchés US
Soins de Santé
RIGL
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
17 M
17.17 M
17.37 M
17.54 M
17.86 M
18.47 M
—
Valuation ratios
Enterprise value
604.07 M
456.83 M
249.21 M
283.55 M
303.99 M
803.52 M
2.01 B
Price to earnings ratio
—
-24.09
-3.94
-10.43
16.99
2.2
18.83
Price to sales ratio
—
3.03
1.92
2.17
1.66
2.74
7.41
Price to cash flow ratio
—
76.86
-3.13
-44.24
9.45
10.67
32.32
Price to book ratio
—
14.87
-16.97
-8.87
90.48
2.06
-5.29
Enterprise value to EBITDA ratio
-19.98
-30.85
-3.72
-10.74
9.99
5.98
19.18
Profitability ratios
Return on assets %
-0.27
-0.11
-0.44
-0.21
0.11
0.71
0.99
Return on equity %
-0.87
-0.59
4.3
0.88
5.32
0.94
2.27
Return on invested capital %
-167.5
-90.01
-299.96
-164.29
155.66
736.83
959.1
Gross margin %
99.18
99.27
98.55
93.92
89.6
93.33
371.93
Operating margin %
-26.67
-8.37
-46.2
-17.53
13.49
42.63
158.15
EBITDA margin %
-26.02
-9.47
-46.6
-17.78
13.61
42.64
170.9
Net margin %
-27.38
-12
-48.71
-21.47
9.75
124.72
504.29
Liquidity ratios
Quick ratio
2.14
2.33
1.64
1.76
2.04
2.3
8.47
Current ratio
2.18
2.43
1.78
1.86
2.13
2.42
8.92
Inventory turnover
0.6
0.26
0.22
0.97
3.24
2.24
2.31
Asset turnover
0.84
1.07
0.8
0.93
1.28
0.87
1.34
Solvency ratios
Debt to assets ratio
0.36
0.12
0.31
0.51
0.37
0.1
0.99
Debt to equity ratio
1.15
0.68
-3.01
-2.1
18.33
0.14
4.67
Long term debt to total assets ratio
0.18
0.12
0.3
0.51
0.37
0.1
0.98
Long term debt to total equity ratio
0.59
0.66
-2.94
-2.09
18.25
0.13
4.61
Per share metrics
Operating cash flow per share
—
0.34
-4.28
-0.33
1.78
4.02
4.05
EBIT per share
—
-0.73
-3.22
-1.18
1.37
6.66
6.78
EBITDA per share
—
-0.83
-3.25
-1.19
1.38
6.66
7.25
Total debt per share
—
1.22
2.38
3.46
3.41
2.81
12.66
Cash per share
—
7.33
3.38
3.27
4.37
8.23
25.61
Net current asset value per share
—
9.06
6.72
5.7
7.64
12.75
41.69
Tangible book value per share
—
1.78
-1.66
-2.44
-1.35
19.47
26.93
Working capital per share
—
5.33
2.94
2.64
4.06
7.48
23.06
Book value per share
—
1.78
-0.79
-1.65
0.19
20.78
32.45
Nouvelles
Rigel Pharmaceuticals Was Easy To Dismiss - Now It's Hard To Ignore (NASDAQ:RIGL)
Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?
Micron and Coinbase among market cap stock movers on Wednesday
Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript
Résultats T4 2025 de Rigel : croissance annuelle de 60 %, données prometteuses sur le SMD
Rigel Q4 2025 slides: 60% annual growth, promising MDS data
Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates
X4 Pharmaceuticals: An Undercovered Biotech Trade With A Funded Path To FDA Approval
Sanofi's Wayrilz Gets Orphan Drug Tag for IgG4-Related Disease in Japan
Implied Volatility Surging for Rigel Pharmaceuticals Stock Options
Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline
Xencor (XNCR) Reports Q4 Loss, Tops Revenue Estimates